Literature DB >> 3432537

Diagnosis of dementia in cancer patients. Cognitive impairment in these patients can go unrecognized.

B D Davis, F Fernandez, F Adams, V Holmes, J K Levy, D Lewis, J Neidhart.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3432537     DOI： 10.1016/S0033-3182(87)72542-0

Source DB:  PubMed          Journal:  Psychosomatics        ISSN： 0033-3182            Impact factor:   2.386


× No keyword cloud information.
  2 in total

1.  Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU) terminated by severe neurologic toxicity.

Authors:  J L Abbruzzese; S Schmidt; M N Raber; J K Levy; A M Castellanos; S S Legha; I H Krakoff
Journal:  Invest New Drugs       Date:  1989-07       Impact factor: 3.850

2.  Assessing the Effects of Redox Modifier MnTnBuOE-2-PyP 5+ on Cognition and Hippocampal Physiology Following Doxorubicin, Cyclophosphamide, and Paclitaxel Treatment.

Authors:  Taylor McElroy; Taurean Brown; Fred Kiffer; Jing Wang; Stephanie D Byrum; Rebecca E Oberley-Deegan; Antiño R Allen
Journal:  Int J Mol Sci       Date:  2020-03-09       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.